Clinical Trial Update: A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects. [Phase 3]

View source ↗

Summary

Phase 3 study assessing the safety and effects of rimegepant for migraine prevention in Chinese subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Rimegepant (rimegepant)

Snippet

Sponsor: Pfizer | Conditions: Migraine | Phase 3 | Status: COMPLETED